MDHearing Neo XS vs Yeasound RIC700

The MDHearing Neo XS is a budget OTC hearing aid featuring an invisible-in-ear design, priced at $397. In our lab testing, it earned a C grade with a SoundScore of 2.9/5, ranking #63 of 65 devices in the OTC hearing aid category. This device presents a mixed performance profile. Its standout strength is excellent feedback handling at 5.0/5, scoring 0.46 points above the category average—meaning users should experience minimal whistling or squealing during everyday use. Own-voice comfort is also solid at 3.2/5, sitting 0.69 points above average, which suggests the device manages occlusion reasonably well for its invisible design. However, speech clarity is a significant weakness. Speech in quiet scored just 1.0/5, falling 1.77 points below the category average, while speech in noise scored 1.0/5, sitting 0.48 points below average. Music streaming scored 0.0/5, coming in 1.92 points below average—indicating this device is not suitable for audio entertainment. These low absolute scores mean users may struggle to achieve meaningful speech benefit in our standardized test conditions. The invisible-in-ear form factor and rechargeable batteries offer convenience, but buyers should weigh this against the limited speech performance. Several competitors in the same price range—including the Elehear Beyond (4.34/5) and Apple AirPods Pro 2 (4.04/5)—deliver substantially better sound quality. The Neo XS may appeal to those prioritizing discretion and feedback-free wear over speech clarity, but most users seeking improved communication would benefit from exploring higher-performing alternatives.

The Yeasound RIC700 is a budget-priced OTC hearing aid that delivers A-grade performance in HearAdvisor's lab testing, placing it in the top 14% of the 65 OTC devices we've evaluated. At $399, it offers strong value for consumers seeking quality amplification without prescription-level costs. In our testing, the RIC700 excels at speech clarity in quiet environments, scoring 4.2/5—a strong result that sits 1.41 points above the OTC category average. Speech understanding in noisy settings scores 1.9/5, which is above the category average but remains low in absolute terms, a common limitation across OTC devices. Music streaming quality reaches 2.9/5, nearly a full point above the category average, though still mixed overall. Feedback handling is excellent at 4.6/5. The device does show some limitations. Own-voice comfort scores 2.0/5, falling 0.51 points below the category average—users may notice some occlusion effects when speaking. This behind-the-ear style features rechargeable batteries and supports both iPhone and Android streaming with hands-free capability. The RIC700 competes well within its price bracket, though shoppers should note that the higher-ranked Yeasound RIC800 and Sony CRE-E10 are available at similar price points with stronger overall scores. For budget-conscious consumers prioritizing speech clarity in quieter listening situations, the RIC700 represents a solid option in the OTC market.